These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6697326)

  • 41. The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress.
    Amellem O; Stokke T; Sandvik JA; Pettersen EO
    Exp Cell Res; 1996 Aug; 227(1):106-15. PubMed ID: 8806457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modification of the action of misonidazole. I. Effect of TAN on toxicity.
    Skov KA; Palcic B; Harrison IE; Skarsgard LD
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Jun; 37(6):601-11. PubMed ID: 6968295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors.
    O'Brien MC; Healy SF; Raney SR; Hurst JM; Avner B; Hanly A; Mies C; Freeman JW; Snow C; Koester SK; Bolton WE
    Cytometry; 1997 May; 28(1):81-9. PubMed ID: 9136759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
    Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
    Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
    Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB
    Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New antitumor agents containing the anthracene nucleus.
    Wunz TP; Dorr RT; Alberts DS; Tunget CL; Einspahr J; Milton S; Remers WA
    J Med Chem; 1987 Aug; 30(8):1313-21. PubMed ID: 2441053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells.
    Potmesil M; Kirschenbaum S; Israel M; Levin M; Khetarpal VK; Silber R
    Cancer Res; 1983 Aug; 43(8):3528-33. PubMed ID: 6861125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Light, fluorescent, and electron microscopic analysis of cultured breast tumor cells (T-47D) treated with 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride.
    Tseng MT; Safa AR
    Cancer Res; 1983 Dec; 43(12 Pt 1):5910-4. PubMed ID: 6640539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of bleomycin cytotoxicity in cultured mammalian cells by polyacrylic acid. III. Induction of DNA strand breakage and suppression of cellular heat production.
    Sarai K; Kohda K; Hayatsu H; Miyamae T; Kawazoe Y
    Anticancer Res; 1991; 11(2):957-60. PubMed ID: 1712183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxicity of phenothiazines: studies with aerated and hypoxic cells.
    Lehnert S
    Res Commun Chem Pathol Pharmacol; 1987 Jun; 56(3):361-74. PubMed ID: 3628966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo and in vitro metabolism of the new anticancer drug bisantrene.
    Peng YM; Alberts DS; Davis TP
    Cancer Chemother Pharmacol; 1985; 14(1):15-20. PubMed ID: 3965156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative studies concerning the uptake of mouse thymus DNA by L1210 leukemia cells.
    Glick JL
    Cancer Res; 1967 Dec; 27(12):2350-6. PubMed ID: 6082283
    [No Abstract]   [Full Text] [Related]  

  • 54. Methylthio-capping of selenocysteamine: preliminary studies on selective toxicity for cancer chemotherapy.
    Pierson HF; Fisher JM; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):447-50. PubMed ID: 4081326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The radiomimetic enediyne, 20'-deschloro-C-1027 induces inter-strand DNA crosslinks in hypoxic cells and overcomes cytotoxic radioresistance.
    Beerman TA; Gawron LS; Shen B; Kennedy DR
    DNA Repair (Amst); 2014 Sep; 21():165-70. PubMed ID: 24986640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of contrasting effects of exogenous DNA on L1210 cell viability.
    Glick JL
    Cancer Res; 1970 Jan; 30(1):138-46. PubMed ID: 5441072
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug resistance of hypoxic tumour cells in vitro.
    Ludwig C
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():173-8. PubMed ID: 6428739
    [No Abstract]   [Full Text] [Related]  

  • 58. Bisantrene, biological and clinical effects.
    Coltman CA; Osborne CK
    Cancer Treat Rev; 1984 Dec; 11(4):285-8. PubMed ID: 6534510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sectional analysis of tumor colony growth in the soft-agar assay: effects of oxygen.
    Fan D; Fan S; Morgan LR
    J Cancer Res Clin Oncol; 1984; 108(2):181-5. PubMed ID: 6540780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancer.
    Weiss GR; Hersh M; Kuhn JG; Ludden TM; von Hoff DD; Kisner DL; Pirtle TE
    Cancer Chemother Pharmacol; 1985; 15(2):144-8. PubMed ID: 4017163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.